Literature DB >> 18522683

Decreased oxidation susceptibility of plasma low density lipoproteins in patients with Gilbert's syndrome.

Zeki Yesilova1, Muhittin Serdar, C Nuri Ercin, Alp Gunay, Guldem Kilciler, Adnan Hasimi, Ahmet Uygun, Ismail Kurt, M Kemal Erbil, Kemal Dagalp.   

Abstract

BACKGROUND AND AIM: The association of hyperbilirubinemia in Gilbert's syndrome (GS) with a decrease in prevalence of coronary artery disease is a well-known phenomenon. In this study, the state of low-density lipoprotein (LDL) oxidation which has been postulated to be a significant determinant at the etiopathogenesis of atherosclerotic disorders was investigated among individuals with GS.
METHODS: For this purpose, serum cholesterol, LDL cholesterol, high-density lipoprotein cholesterol, triglycerides, uric acid, apolipoprotein A and B, bilirubins, thiobarbituric acid-reactive substances, and the sensitivity of LDL oxidation levels, as well as serum alanine aminotransferase, aspartate aminotranserfase, gamma glutamyl transferase, and alkaline phosphatase activities, were determined in 17 patients with Gilbert's syndrome and 15 healthy adults.
RESULTS: There was no significant difference between the groups except the indirect bilirubin parameter (P < 0.001). In comparison with the healthy individuals, LDL oxidation levels between 75 and 120 min were significantly lower (P < 0.005) along with prolonged lag-phase in GS patients, indicating a delay in oxidation susceptibility.
CONCLUSION: It is suggested that the chronic hyperbilirubinemia leading to a lag-phase prolongation in LDL oxidation and a decrease in LDL oxidation may be reason for the low percentage of coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18522683     DOI: 10.1111/j.1440-1746.2008.05388.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  13 in total

1.  Developmental hyperbilirubinemia and CNS toxicity in mice humanized with the UDP glucuronosyltransferase 1 (UGT1) locus.

Authors:  Ryoichi Fujiwara; Nghia Nguyen; Shujuan Chen; Robert H Tukey
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-01       Impact factor: 11.205

2.  A possible cross-sectional association of serum total bilirubin with coronary heart disease and stroke in a Japanese health screening population.

Authors:  Eiji Oda; Ryu Kawai
Journal:  Heart Vessels       Date:  2011-03-11       Impact factor: 2.037

Review 3.  Heme oxygenase-1: a metabolic nike.

Authors:  Barbara Wegiel; Zsuzsanna Nemeth; Matheus Correa-Costa; Andrew C Bulmer; Leo E Otterbein
Journal:  Antioxid Redox Signal       Date:  2014-02-27       Impact factor: 8.401

4.  A cohort study of serum bilirubin levels and incident non-alcoholic fatty liver disease in middle aged Korean workers.

Authors:  Yoosoo Chang; Seungho Ryu; Yiyi Zhang; Hee Jung Son; Jang-Young Kim; Juhee Cho; Eliseo Guallar
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

5.  Reduced circulating oxidized LDL is associated with hypocholesterolemia and enhanced thiol status in Gilbert syndrome.

Authors:  Ai-Ching Boon; Clare L Hawkins; Kavita Bisht; Jeff S Coombes; Bhavisha Bakrania; Karl-Heinz Wagner; Andrew C Bulmer
Journal:  Free Radic Biol Med       Date:  2012-04-14       Impact factor: 7.376

6.  Longitudinal Blood Pressure Control, Long-Term Mortality, and Predictive Utility of Serum Liver Enzymes and Bilirubin in Hypertensive Patients.

Authors:  Linsay McCallum; Jeemon Panniyammakal; Claire E Hastie; Jonathan Hewitt; Rajan Patel; Gregory C Jones; Scott Muir; Matthew Walters; Naveed Sattar; Anna F Dominiczak; Sandosh Padmanabhan
Journal:  Hypertension       Date:  2015-05-04       Impact factor: 10.190

7.  Mildly elevated serum bilirubin levels are negatively associated with carotid atherosclerosis among elderly persons.

Authors:  Ryuichi Kawamoto; Daisuke Ninomiya; Yoichi Hasegawa; Yoshihisa Kasai; Tomo Kusunoki; Nobuyuki Ohtsuka; Teru Kumagi; Masanori Abe
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

8.  Potential cardiovascular risk protection of bilirubin in end-stage renal disease patients under hemodialysis.

Authors:  Maria do Sameiro-Faria; Michaela Kohlova; Sandra Ribeiro; Petronila Rocha-Pereira; Laetitia Teixeira; Henrique Nascimento; Flávio Reis; Vasco Miranda; Elsa Bronze-da-Rocha; Alexandre Quintanilha; Luís Belo; Elísio Costa; Alice Santos-Silva
Journal:  Biomed Res Int       Date:  2014-09-10       Impact factor: 3.411

9.  The Pleiotropic Effects of Atorvastatin on Stable Angina Patients: Evidence by Analysis of High-Density Lipoprotein Size and Subclasses, and Plasma mRNA.

Authors:  Bosa Mirjanić-Azarić; Zorana Jelić-Ivanović; Aleksandra Zeljković; Jelena Vekić; Günther Jürgens; Tatjana Milivojac; Sanja Avram; Jozo Ćorić; Janja Marc; Darko Černe
Journal:  J Med Biochem       Date:  2015-07-14       Impact factor: 3.402

10.  Exposure to lipopolysaccharide and/or unconjugated bilirubin impair the integrity and function of brain microvascular endothelial cells.

Authors:  Filipa L Cardoso; Agnes Kittel; Szilvia Veszelka; Inês Palmela; Andrea Tóth; Dora Brites; Mária A Deli; Maria A Brito
Journal:  PLoS One       Date:  2012-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.